Clara D. Bloomfield
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.01%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 269
- Acute Myeloid Leukemia Research 242
- Chronic Myeloid Leukemia Treatments 84
-
- Retinoids in leukemia and cellular processes 30
- Protein Degradation and Inhibitors 30
- Co-authors
- James W. Vardiman (25 shared papers)Michelle M. Le Beau (4 shared papers)Krzysztof Mrózek (113 shared papers)Michael J. Borowitz (3 shared papers)Daniel A. Arber (3 shared papers)Hartmut Döhner (11 shared papers)Daniel J. Weisdorf (3 shared papers)Richard A. Larson (105 shared papers)
- Journals
- Blood (104 papers)Journal of Clinical Oncology (40 papers)Cancer (30 papers)Proceedings of the National Academy of Sciences (12 papers)Leukemia (12 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Clara D. Bloomfield
402 papers receiving 42.1k citations
Clara D. Bloomfield's Hit Papers
Peers
Comparison fields: 5 of 171
- Hematology 26.5k
- Genetics 10.4k
- Cancer Research 4.7k
- Public Health, Environmental and Occupational Health 8.1k
- Pathology and Forensic Medicine 4.7k
Countries citing papers authored by Clara D. Bloomfield
This map shows the geographic impact of Clara D. Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara D. Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara D. Bloomfield more than expected).
Fields of papers citing papers by Clara D. Bloomfield
This network shows the impact of papers produced by Clara D. Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara D. Bloomfield. The network helps show where Clara D. Bloomfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Clara D. Bloomfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 409 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Hit paper breakdown → | 2016 | 6165 |
| 2 | The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Hit paper breakdown → | 2009 | 3014 |
| 3 | World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997 Hit paper breakdown → | 1999 | 2499 |
| 4 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2370 |
| 5 | Acute Myeloid Leukemia Hit paper breakdown → | 2015 | 2345 |
| 6 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 1890 |
| 7 | All-trans-Retinoic Acid in Acute Promyelocytic Leukemia Hit paper breakdown → | 1997 | 810 |
| 8 | Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Hit paper breakdown → | 2007 | 604 |
| 9 | IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study Hit paper breakdown → | 2010 | 555 |
| 10 | Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Hit paper breakdown → | 1998 | 509 |
| 11 | 2003 | 482 | |
| 12 | Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. | 2001 | 470 |
| 13 | 2008 | 465 | |
| 14 | 2006 | 464 | |
| 15 | 2008 | 400 | |
| 16 | 2006 | 397 | |
| 17 | 2005 | 371 | |
| 18 | 2006 | 350 | |
| 19 | 2008 | 319 | |
| 20 | 2008 | 315 |
About Clara D. Bloomfield
Clara D. Bloomfield is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Genetics and Pathology and Forensic Medicine, having authored 409 papers that have together received 43.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (242 papers), Acute Lymphoblastic Leukemia research (115 papers), Chronic Myeloid Leukemia Treatments (84 papers), Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (55 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (33 papers), Retinoids in leukemia and cellular processes (30 papers) and Protein Degradation and Inhibitors (30 papers). The work is most often cited by research in Hematology (26.5k citations), Genetics (10.4k citations), Cancer Research (4.7k citations), Public Health, Environmental and Occupational Health (8.1k citations) and Pathology and Forensic Medicine (4.7k citations). Clara D. Bloomfield has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include James W. Vardiman, Michelle M. Le Beau, Krzysztof Mrózek, Michael J. Borowitz, Daniel A. Arber, Hartmut Döhner, Daniel J. Weisdorf, Richard A. Larson, Guido Marcucci and Attilio Orazi. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Proceedings of the National Academy of Sciences and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.